Credit Suisse’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $161K | Buy |
81,484
+30,089
| +59% | +$59.3K | ﹤0.01% | 2909 |
|
|
2023
Q4 | $72.5K | Sell |
51,395
-254,661
| -83% | -$359K | ﹤0.01% | 3027 |
|
|
2023
Q3 | $395K | Sell |
306,056
-114,745
| -27% | -$148K | ﹤0.01% | 2803 |
|
|
2023
Q2 | $724K | Buy |
420,801
+108,078
| +35% | +$186K | ﹤0.01% | 2581 |
|
|
2023
Q1 | $566K | Buy |
312,723
+37
| +0% | +$67 | ﹤0.01% | 2667 |
|
|
2022
Q4 | $832K | Sell |
312,686
-11,069
| -3% | -$29.4K | ﹤0.01% | 2450 |
|
|
2022
Q3 | $1.07M | Buy |
323,755
+10,026
| +3% | +$33.2K | ﹤0.01% | 2266 |
|
|
2022
Q2 | $1.14M | Buy |
+313,729
| New | +$1.14M | ﹤0.01% | 2284 |
|